Traffic and Industrial Pollutants Tied to Chronic Rhinosinusitis Risk
via HealthDayFRIDAY, May 29, 2026 (Health Day News) -- Long-term residential exposure to traffic-related and industry-related pollutants is associated with increased chronic rhinosinusitis (CRS) risk, according to a study published online May 28 in JAMA Otolaryngology-Head & Neck Surgery.
Hong-Ho Yang, M.D., from the Stanford University School of Medicine in California, and colleagues investigated the association between long-term residential exposure to traffic-related and industry-related pollutants and CRS risk. The analysis included data from 92 participants, including sinonasal epithelial specimens from endoscopic sinus surgery (62 with CRS) and 30 skull base surgery controls (2018 to 2021).
The researchers found that when adjusting for demographic characteristics, smoking history, steroid use, and comorbidities, each standard deviation increase in nitrogen dioxide (NO2) levels was independently associated with an increase in odds of CRS (adjusted odds ratio [aOR], 2.32). Similarly, increases in CRS were seen with increasing benzene (aOR, 2.15) and lead levels (aOR, 3.48). When adjusting for CRS status and copollutant levels, NO2 exposure was associated with elevated interleukin (IL)-4, IL-5, IL-13, and tumor necrosis factor α levels, while benzene was associated with suppressed IL-1 receptor agonist levels and lead was associated with elevated IL-8 and IL-1 receptor agonist levels.
"Long-term residential exposure to traffic-related and industry-related pollutants was associated with distinct sinonasal inflammatory signatures and endotypic diversity, suggesting pollutant-specific pathways that may contribute to heterogeneous chronic rhinosinusitis pathophysiology," the authors write.
Two authors disclosed ties to the pharmaceutical and medical device industries.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-30 03:14
Read more
- Worse Self-Rated Health Seen for Adults With Poor Mental Health Worldwide
- Regeneron Provides Update on Phase 3 Trial of Fianlimab (LAG-3 Inhibitor) Combination in First-Line Unresectable or Metastatic Melanoma
- Researchers Identify First Suite of Human Antibodies Against Measles Virus
- ASMBS: Metabolic, Bariatric Surgery Bests GLP-1 Receptor Agonists for 12-Month Weight Loss
- Preop Fine Particulate Matter Exposure Tied to Increased Risk for Postop Complications
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions